Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Assets Average: 2020-2021

Historic Assets Average for Black Diamond Therapeutics (BDTX) over the last 2 years, with Sep 2021 value amounting to $281.0 million.

  • Black Diamond Therapeutics' Assets Average fell 19.24% to $281.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $281.0 million, marking a year-over-year decrease of 19.24%. This contributed to the annual value of $244.0 million for FY2020, which is 132.23% up from last year.
  • According to the latest figures from Q3 2021, Black Diamond Therapeutics' Assets Average is $281.0 million, which was down 6.51% from $300.6 million recorded in Q2 2021.
  • In the past 5 years, Black Diamond Therapeutics' Assets Average ranged from a high of $356.1 million in Q2 2020 and a low of $260.5 million during Q1 2020.
  • Over the past 2 years, Black Diamond Therapeutics' median Assets Average value was $321.5 million (recorded in 2021), while the average stood at $315.1 million.
  • Data for Black Diamond Therapeutics' Assets Average shows a peak YoY increase of 23.38% (in 2021) and a maximum YoY decrease of 19.24% (in 2021) over the last 5 years.
  • Over the past 2 years, Black Diamond Therapeutics' Assets Average (Quarterly) stood at $338.1 million in 2020, then dropped by 19.24% to $281.0 million in 2021.
  • Its last three reported values are $281.0 million in Q3 2021, $300.6 million for Q2 2021, and $321.5 million during Q1 2021.